133 related articles for article (PubMed ID: 37761305)
21. Soluble Urokinase-Type Plasminogen Activator Receptor, Changes of 24-Hour Blood Pressure, and Progression of Chronic Kidney Disease.
Jhee JH; Nam BY; Lee CJ; Park JT; Han SH; Kang SW; Park S; Yoo TH
J Am Heart Assoc; 2021 Jan; 10(1):e017225. PubMed ID: 33325248
[TBL] [Abstract][Full Text] [Related]
22. Cumulative childhood risk is associated with a new measure of chronic inflammation in adulthood.
Rasmussen LJH; Moffitt TE; Eugen-Olsen J; Belsky DW; Danese A; Harrington H; Houts RM; Poulton R; Sugden K; Williams B; Caspi A
J Child Psychol Psychiatry; 2019 Feb; 60(2):199-208. PubMed ID: 29741788
[TBL] [Abstract][Full Text] [Related]
23. Soluble urokinase plasminogen activator receptor levels are elevated and associated with complications in patients with type 1 diabetes.
Theilade S; Lyngbaek S; Hansen TW; Eugen-Olsen J; Fenger M; Rossing P; Jeppesen JL
J Intern Med; 2015 Mar; 277(3):362-371. PubMed ID: 24830873
[TBL] [Abstract][Full Text] [Related]
24. Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus.
Enocsson H; Wetterö J; Skogh T; Sjöwall C
Transl Res; 2013 Nov; 162(5):287-96. PubMed ID: 23916811
[TBL] [Abstract][Full Text] [Related]
25. Predicting Mortality in African Americans With Type 2 Diabetes Mellitus: Soluble Urokinase Plasminogen Activator Receptor, Coronary Artery Calcium, and High-Sensitivity C-Reactive Protein.
Hayek SS; Divers J; Raad M; Xu J; Bowden DW; Tracy M; Reiser J; Freedman BI
J Am Heart Assoc; 2018 May; 7(9):. PubMed ID: 29716888
[TBL] [Abstract][Full Text] [Related]
26. Independent impact of periodontitis and cardiovascular disease on elevated soluble urokinase-type plasminogen activator receptor (suPAR) levels.
Isola G; Polizzi A; Alibrandi A; Williams RC; Leonardi R
J Periodontol; 2021 Jun; 92(6):896-906. PubMed ID: 33091149
[TBL] [Abstract][Full Text] [Related]
27. Soluble urokinase-type plasminogen activator receptor predicts peripheral artery disease severity and outcomes.
Höbaus C; Ursli M; Yussef SM; Wrba T; Koppensteiner R; Schernthaner GH
Vasc Med; 2021 Feb; 26(1):11-17. PubMed ID: 33448911
[TBL] [Abstract][Full Text] [Related]
28. The Plasma Soluble Urokinase Plasminogen Activator Receptor Is Related to Disease Activity of Patients with ANCA-Associated Vasculitis.
Huang F; Li Y; Xu R; Cheng A; Lv Y; Liu Q
Mediators Inflamm; 2020; 2020():7850179. PubMed ID: 32322165
[TBL] [Abstract][Full Text] [Related]
29. Soluble urokinase-type plasminogen activator levels are related to plasma cytokine levels but have low predictive value for mortality in trauma patients.
Timmermans K; Vaneker M; Scheffer GJ; Maassen P; Janssen S; Kox M; Pickkers P
J Crit Care; 2015 Jun; 30(3):476-80. PubMed ID: 25721031
[TBL] [Abstract][Full Text] [Related]
30. Urine soluble urokinase plasminogen activator receptor as a potential biomarker of lupus nephritis activity.
Burcsár S; Toldi G; Kovács L; Szalay B; Vásárhelyi B; Balog A
Biomarkers; 2021 Jul; 26(5):443-449. PubMed ID: 33825610
[TBL] [Abstract][Full Text] [Related]
31. Value of soluble Urokinase plasminogen activator receptor over age as a biomarker of impaired myocardial relaxation.
Koh AS; Velmurugan B; Gao F; Tan RS; Wong JI; Teo LLY; Keng BMH; Chua SJM; Yuan JM; Koh WP; Cheung C
BMC Geriatr; 2017 Nov; 17(1):275. PubMed ID: 29179674
[TBL] [Abstract][Full Text] [Related]
32. Circulating soluble urokinase plasminogen activator receptor levels and peripheral arterial disease outcomes.
Samman Tahhan A; Hayek SS; Sandesara P; Hajjari J; Hammadah M; O'Neal WT; Kelli HM; Alkhoder A; Ghasemzadeh N; Ko YA; Aida H; Gafeer MM; Abdelhadi N; Mohammed KH; Patel K; Arya S; Reiser J; Vaccarino V; Sperling L; Quyyumi A
Atherosclerosis; 2017 Sep; 264():108-114. PubMed ID: 28728756
[TBL] [Abstract][Full Text] [Related]
33. The prognostic value of plasma soluble urokinase plasminogen activator receptor (suPAR) levels in stage III ovarian cancer patients.
Begum FD; Høgdall CK; Kjaer SK; Christensen L; Blaakaer J; Bock JE; Glud E; Høyer-Hansen G; Ring-Larsen H; Høgdall EV
Anticancer Res; 2004; 24(3b):1981-5. PubMed ID: 15274388
[TBL] [Abstract][Full Text] [Related]
34. Soluble urokinase plasminogen activator receptor is associated with inflammation in the vulnerable human atherosclerotic plaque.
Edsfeldt A; Nitulescu M; Grufman H; Grönberg C; Persson A; Nilsson M; Persson M; Björkbacka H; Gonçalves I
Stroke; 2012 Dec; 43(12):3305-12. PubMed ID: 23150653
[TBL] [Abstract][Full Text] [Related]
35. The Prognostic Significance of Soluble Urokinase Plasminogen Activator Receptor in Acute Myeloid Leukemia.
Erkut N; Menteşe A; Özbaş HM; Ermantaş N; Sümer A; Örem A; Sönmez M
Turk J Haematol; 2016 Jun; 33(2):135-40. PubMed ID: 26376588
[TBL] [Abstract][Full Text] [Related]
36. Soluble Urokinase-Type Plasminogen Activator Receptor and Arterial Stiffness in Patients with COPD.
Böcskei RM; Benczúr B; Losonczy G; Illyés M; Cziráki A; Müller V; Bohács A; Bikov A
Lung; 2019 Apr; 197(2):189-197. PubMed ID: 30820636
[TBL] [Abstract][Full Text] [Related]
37. Circulating Soluble Urokinase-Type Plasminogen Activator Receptor in Obstructive Sleep Apnoea.
Bocskei RM; Meszaros M; Tarnoki AD; Tarnoki DL; Kunos L; Lazar Z; Bikov A
Medicina (Kaunas); 2020 Feb; 56(2):. PubMed ID: 32075014
[No Abstract] [Full Text] [Related]
38. Healthy lifestyles reduce suPAR and mortality in a Danish general population study.
Haupt TH; Rasmussen LJH; Kallemose T; Ladelund S; Andersen O; Pisinger C; Eugen-Olsen J
Immun Ageing; 2019; 16():1. PubMed ID: 30679937
[TBL] [Abstract][Full Text] [Related]
39. Serum soluble urokinase plasminogen activator receptor (suPAR) in adults with growth hormone deficiency.
Höybye C; Faseh L; Himonakos C; Pielak T; Eugen-Olsen J
Endocr Connect; 2019 Jun; 8(6):772-779. PubMed ID: 31151091
[TBL] [Abstract][Full Text] [Related]
40. Plasma Soluble Urokinase Plasminogen Activator Receptor Levels in Systemic Lupus Erythematosus Patients.
Zaitoon YA; Shehab AA; Mohamed NA; Morad CS; Yassine EM
Egypt J Immunol; 2018 Jan; 25(1):35-43. PubMed ID: 30242996
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
